The Geometry of ATG-Walks of the Omicron SARS CoV-2 Virus RNAs
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
In this message, the complete RNA sequences (GISAID) of Omicron (BA.1 and BA.2) SARS CoV-2 viruses are studied using the genomic ATG-walks. These walks are compared visually and numerically with a reference RNA (Wuhan, China, 2020), and the deviation levels are estimated. Statistical characteristics of these distributions are compared, including the fractal dimension values of coding-word length distributions. Most of the 17 RNA ATG walks studied here show relatively small deviations of their characteristics and resistance to forming a new virus family.
Article activity feed
-
SciScore for 10.1101/2021.12.20.473613: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
No key resources detected.
Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when …
SciScore for 10.1101/2021.12.20.473613: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
No key resources detected.
Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-